Pyridine Sortilin Modulators for Blocking Apoptotic Complex Formation

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

There is an unmet need for new compounds that can modulate sortilin activity to treat or prevent conditions such as neurodegenerative disorders, cancer, pain, diabetes mellitus, diabetic retinopathy, cardiovascular disease, hereditary eye conditions, and hearing loss.

Innovation Solution

Development of pyridine derivatives that inhibit or antagonize sortilin by disrupting the interaction between sortilin and pro-neurotrophins or p75NTR, preventing the formation of a trimeric complex that induces apoptosis.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If sortilin activity is modulated to treat medical conditions, then therapeutic efficacy is improved, but safety and side effects must be managed

Engineering Contradiction:

Improvetherapeutic efficacyVSAvoidside effects

Core Design Contradiction:

ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent modifies the chemical structure of sortilin modulators by changing parameters such as introducing specific functional groups (carboxylic acid, hydroxyl, amino) at defined positions (R1, R2, R3) and adjusting molecular weight and lipophilicity to optimize therapeutic efficacy while reducing side effects

Inventive Principle:

Principle #35Parameter changes

Solution Approach 2:

The invention applies local modifications to specific regions of the sortilin binding site, with different substituents at R1, R2, and R3 positions targeting specific interaction sites to achieve condition-specific modulation with minimized off-target effects

Inventive Principle:

Principle #3Local quality

2Reliability

If new compounds are developed to modulate sortilin activity, then treatment effectiveness is improved, but development complexity increases

Engineering Contradiction:

Improvetreatment effectivenessVSAvoiddevelopment complexity

Core Design Contradiction:

ReliabilityVSDevice complexity

Solution Approach 1:

The patent divides the sortilin modulator molecule into distinct segments with specific functional groups at defined positions (R1, R2, R3), allowing independent optimization of each segment for specific therapeutic properties while maintaining overall molecular coherence

Inventive Principle:

Principle #1Segmentation

Solution Approach 2:

The invention creates a universal scaffold structure that can be applied across multiple medical conditions by modifying specific positions (R1-R3) to target different sortilin interactions, reducing the need for entirely new compound development for each indication

Inventive Principle:

Principle #6Universality (Multi-functionality)

Data Source

PatentUS12630558B2Pyridine derivatives as modulators of sortilin activity

Publication Date: 2026.05.19 VESPER BIO APS

AI summary

The present invention relates to compounds of formula (I), which are modulators of sortilin activity. The invention also relates to pharmaceutical compositions comprising these compounds and to the use of these compounds in the treatment or prevention of medical conditions where modulation of sortilin activity is beneficial.